Most dogs diagnosed with Cushing’s disease live roughly one and a half to three years after diagnosis when the condition is managed with medication, though the range is wide. A large UK study of 219 dogs found a median survival of about 510 days from first diagnosis, while other studies of dogs on optimized drug protocols have reported medians closer to 900 or even 1,000 days.1PubMed Central. Survival analysis of 219 dogs with hyperadrenocorticism attending primary care practice in England The numbers depend heavily on whether the disease originates in the pituitary gland or the adrenal gland, whether treatment is pursued, and what complications develop along the way.
What the Survival Numbers Actually Show
Survival statistics in veterinary medicine tend to be messier than people expect. The 510-day median from the large UK primary-care study means that half the dogs in the study lived longer than that and half died sooner. But that figure captures a mixed group: dogs that were treated, dogs that were not, and dogs at various stages of disease at the time of diagnosis.1PubMed Central. Survival analysis of 219 dogs with hyperadrenocorticism attending primary care practice in England When researchers look specifically at dogs receiving treatment with trilostane (the most commonly prescribed drug today), some studies report considerably longer medians. One study of dogs receiving twice-daily low-dose trilostane found a median survival of 998 days, with some dogs living past five years.2PubMed. Survival of dogs with pituitary-dependent hyperadrenocorticism treated twice daily with low doses of trilostane Another study reported a median of about 1,245 days for dogs with Cushing’s alone.3PubMed. Effects of concurrent canine Cushing’s syndrome and diabetes Mellitus on insulin requirements, trilostane dose, and survival time
The spread between these numbers reflects differences in study design, how early dogs were diagnosed, and the treatment protocols used. A primary-care population inevitably includes dogs caught late, dogs whose owners declined treatment, and dogs with advanced complications. Referral hospital data tends to look better because those dogs are being more aggressively managed. Neither number is “wrong,” but when you hear a vet quote a survival time, it helps to know which kind of population the figure comes from.
Pituitary Versus Adrenal Forms
About 80 to 85 percent of Cushing’s cases in dogs originate from a tiny tumor on the pituitary gland at the base of the brain. These pituitary-dependent cases tend to carry a better prognosis because the tumors are usually small and benign, though they drive the adrenal glands to overproduce cortisol. The remaining cases come from a tumor on one of the adrenal glands themselves.
Adrenal tumors can be benign or malignant, and that distinction matters enormously. In a study of dogs with adrenal-dependent Cushing’s treated with trilostane, the median survival was 353 days, compared to 102 days for those treated with mitotane (an older drug). Dogs whose adrenal tumors had already spread to other organs had a significantly lower chance of survival than those without metastatic disease.4Journal of Veterinary Internal Medicine. A Comparison of Factors that Influence Survival in Dogs with Adrenal-Dependent Hyperadrenocorticism Treated with Mitotane or Trilostane When surgery is feasible, however, the outlook for adrenal tumors improves dramatically. A study of over 300 dogs undergoing adrenalectomy reported that 87 percent survived to discharge and the tumor-related survival time was nearly four years.5PubMed Central. Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumors
For the pituitary form, the tumor itself rarely threatens the dog’s life directly (large pituitary tumors that press on the brain are a notable exception). The damage comes from years of excess cortisol eroding the body’s systems. That is why ongoing medical management can extend life substantially: you are not curing the tumor, but you are keeping cortisol levels in check so that its downstream effects slow down.
How Treatment Changes the Timeline
Trilostane is the standard first-line medication for Cushing’s disease in most countries. It works by blocking an enzyme the adrenal glands need to produce cortisol. A direct comparison between treated and untreated dogs found that untreated dogs had a median survival of about 506 days, while the trilostane-treated group’s median was not even reached during the study period because enough dogs were still alive. Statistical analysis showed that being in the untreated group was associated with roughly five times the hazard of death.6PubMed Central. Comparison of Survival Times for Dogs with Pituitary‐Dependent Hyperadrenocorticism in a Primary‐Care Hospital: Treated with Trilostane versus Untreated
A recent meta-analysis pooling data from several studies found that the survival advantage of trilostane grew over time: survival rates were about 11 percent higher than control at six months, 13 percent at one year, and 9 percent at two years, with a statistically significant 11 percent improvement at three years.7PubMed Central. Effectiveness of Medical Treatment on Survivability in Canine Cushing’s Syndrome: A Systematic Review and Meta-Analysis The early time points did not quite reach statistical significance, but the trend was consistent: treated dogs lived longer at every interval measured.
Mitotane, an older drug that actually destroys adrenal tissue rather than just blocking cortisol production, is used less frequently now because of its more severe side-effect profile. It still has a role in certain refractory cases or when trilostane is not available. Surgery (hypophysectomy for pituitary tumors, adrenalectomy for adrenal tumors) can be curative in some cases, but these procedures require specialized surgical teams and carry real perioperative risk. About one in four dogs undergoing adrenalectomy experienced post-operative complications in the large surgical study.5PubMed Central. Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumors
Complications That Can Shorten Life
Cushing’s disease is not usually what kills a dog directly. The excess cortisol it produces acts like a slow poison across many organ systems, setting up secondary conditions that eventually become life-threatening. Understanding these complications helps explain why two dogs with the same diagnosis can have very different outcomes.
- Blood clots: Dogs with Cushing’s tend to exist in a hypercoagulable state, meaning their blood clots more readily than it should. While studies have confirmed this tendency in most affected dogs, actual clot events like pulmonary thromboembolism remain relatively rare.8Journal of Veterinary Internal Medicine. Assessment of Coagulation and Potential Biochemical Markers for Hypercoagulability in Canine Hyperadrenocorticism When they do occur, though, they can be fatal. One case report describes a dog that survived nearly two years after pituitary surgery before dying suddenly from blood clots in the abdominal aorta and pulmonary artery.9PubMed. Cushing’s disease complicated with thrombosis in a dog
- High blood pressure: Systemic hypertension is common in dogs with Cushing’s and can persist even after treatment begins.10Journal of Veterinary Internal Medicine. Changes in systolic blood pressure in dogs with pituitary dependent hyperadrenocorticism during the first year of trilostane treatment Sustained high blood pressure damages the kidneys, eyes, heart, and brain over time. Research has shown that excess cortisol directly raises blood pressure and increases protein loss through the kidneys, both of which reversed when cortisol levels dropped back to normal.11Journal of Veterinary Internal Medicine. The Effects of Hydrocortisone on Systemic Arterial Blood Pressure and Urinary Protein Excretion in Dogs
- Diabetes: Cortisol works against insulin, so dogs with Cushing’s are at elevated risk for developing diabetes. When both conditions occur together, survival tends to be shorter than for either condition alone. One study found dogs with concurrent Cushing’s and diabetes had a median survival of about 892 days, shorter than dogs with Cushing’s alone or diabetes alone, and the diabetic dogs also needed higher insulin doses.3PubMed. Effects of concurrent canine Cushing’s syndrome and diabetes Mellitus on insulin requirements, trilostane dose, and survival time
- Kidney damage: Dogs with adrenal-dependent Cushing’s in particular showed higher rates of hypertension and protein leakage in the urine (albuminuria) compared to healthy dogs, signaling kidney stress.12PubMed Central. Associations among systemic blood pressure, microalbuminuria and albuminuria in dogs affected with pituitary- and adrenal-dependent hyperadrenocorticism
- Pulmonary mineralization: In some cases, calcium deposits form in the lungs, making it progressively harder for the dog to breathe. This complication can become severe enough that euthanasia becomes necessary because of worsening oxygen deprivation.13Veterinary Radiology & Ultrasound. PULMONARY MINERALIZATION IN FOUR DOGS WITH CUSHING’S SYNDROME
The unpredictability of these complications is a big reason why survival times vary so much. A dog whose Cushing’s is well controlled and who avoids blood clots, kidney failure, or diabetes can live comfortably for years. A dog who develops multiple complications early may decline much faster.
Which Dogs Get Cushing’s and Why It Matters for Prognosis
Cushing’s disease is overwhelmingly a disease of older dogs. The average age at diagnosis in one large epidemiological study was about 9.8 years, and only around 5 percent of cases were in dogs younger than five.14PubMed Central. Cushing’s syndrome—an epidemiological study based on a canine population of 21,281 dogs This matters for survival estimates because dogs diagnosed at 10 or 11 are already approaching the end of a natural lifespan for many breeds. A dog that lives another two to three years with Cushing’s may reach 12 or 13, which is a reasonable life expectancy for a medium-sized dog regardless of Cushing’s.
Certain breeds carry substantially higher risk. The same study found that Standard Schnauzers had dramatically elevated odds of developing Cushing’s, followed by Fox Terriers, Cavalier King Charles Spaniels, Boxers, Shih Tzus, Maltese, Miniature Dachshunds, Miniature Poodles, and Yorkshire Terriers, among others.14PubMed Central. Cushing’s syndrome—an epidemiological study based on a canine population of 21,281 dogs Female dogs and neutered dogs of both sexes also had higher risk. If your dog belongs to one of these predisposed groups, earlier recognition and treatment could translate into a longer comfortable life span, since many of the complications described above accumulate over time.
The Monitoring Challenge
One reason survival varies is that monitoring trilostane treatment is not as straightforward as checking whether symptoms improve. The standard approach involves periodic blood tests to measure cortisol levels after a stimulation test. But research has shown that these test results can overlap substantially between dogs that are well-controlled and dogs that are undercontrolled, making it difficult to rely on lab values alone.15Journal of Veterinary Internal Medicine. Laboratory assessment of trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism
Researchers have explored additional blood markers to fill this gap. One study found that haptoglobin (an inflammation-related protein) and certain liver enzymes could be useful supplementary indicators of whether a dog’s Cushing’s was adequately managed.16Journal of Veterinary Internal Medicine. Comparison of methods to monitor dogs with hypercortisolism treated with trilostane In practice, most vets combine lab results with clinical observation: Is the dog drinking less? Has the pot-bellied appearance improved? Is the coat growing back? Has energy improved? Owners who track these signs closely tend to catch dosing problems earlier, which keeps complications at bay and likely contributes to longer survival.
Quality of Life From the Owner’s Perspective
Survival time is only part of the picture. Cushing’s disease is a chronic condition that requires daily medication, regular vet visits for blood work, and ongoing cost. Researchers who developed a quality-of-life tool specifically for dogs with Cushing’s found something interesting: the areas owners rated as most important to their experience were not the dog’s clinical lab values, but rather the bond between owner and dog and how well the owner felt they were managing the disease.17Journal of Veterinary Internal Medicine. Development and evaluation of a health-related quality-of-life tool for dogs with Cushing’s syndrome In other words, the emotional and practical burden on the owner shaped how the disease was experienced and managed just as much as the dog’s physical symptoms did.
A survey of Flemish and Dutch owners of dogs with Cushing’s confirmed this pattern. The survey highlighted that a negative impact on the owner’s quality of life could lead to stopping medical care or choosing euthanasia, even when the dog’s condition was still treatable.18Vlaams Diergeneeskundig Tijdschrift. Cushing’s syndrome in Flanders and the Netherlands: an owner survey Financial strain, the hassle of frequent vet visits, managing a dog that urinates excessively indoors, and disrupted sleep from a dog needing to go out at night all weigh on the decision to continue treatment. These are not trivial factors. For many owners, the practical reality of managing Cushing’s is the limiting factor on how long a dog lives with the disease, not the disease’s biological ceiling.
When Cushing’s Is Caused by Medication
Not all Cushing’s disease comes from tumors. Iatrogenic Cushing’s (sometimes called iatrogenic hyperadrenocorticism) develops when a dog has been on corticosteroid medications like prednisone for an extended period. The symptoms look identical to naturally occurring Cushing’s: increased thirst and urination, a distended abdomen, thinning skin, and muscle wasting. In one reported case, a dog developed iatrogenic Cushing’s with secondary mineral deposits in the lungs, but clinical signs resolved and lung function returned to normal once the corticosteroid was discontinued.19PubMed Central. Diagnosis and outcome of a dog with iatrogenic hyperadrenocorticism and secondary pulmonary mineralization
This form carries a fundamentally different prognosis. Because the excess cortisol is coming from a pill rather than a tumor, removing the cause (tapering off the steroid, gradually and under veterinary supervision) is usually curative. The key complication is that steroids cannot always be stopped abruptly without triggering a dangerous adrenal crisis, and the underlying condition that required steroids in the first place still needs to be managed with an alternative treatment. But in terms of life expectancy, iatrogenic Cushing’s does not carry the same long-term survival concerns as the naturally occurring disease.
Atypical and Occult Cushing’s Disease
Some dogs present with all the hallmark signs of Cushing’s (excessive drinking, panting, hair loss, a pot belly) but come back with normal results on the standard cortisol screening tests. This confusing presentation has been called “atypical” or “occult” Cushing’s. One theory holds that these dogs overproduce adrenal sex hormones rather than cortisol, which causes similar clinical signs but evades the usual diagnostic tests.20PubMed. Atypical Cushing’s syndrome in dogs: arguments for and against
The existence and nature of atypical Cushing’s remains debated among veterinary endocrinologists. Some specialists argue that these dogs simply have early-stage conventional Cushing’s that has not yet progressed enough to trigger positive screening tests, while others believe the sex-hormone pathway represents a genuinely distinct syndrome. For owners, the practical implication is that a negative screening test in a dog with textbook Cushing’s signs does not necessarily mean Cushing’s is ruled out. Your vet may recommend additional hormone panels, imaging of the adrenal glands, or a period of watchful waiting with repeat testing. Because the diagnosis is uncertain, survival data for this group is sparse. The handful of dogs treated empirically with trilostane or other medications have had variable outcomes, and it is difficult to draw conclusions about expected life span when the underlying disease process is unclear.
When Euthanasia Becomes Part of the Conversation
For many owners, the question is not just “how long can my dog live” but “how will I know when it is time.” Cushing’s disease rarely presents a clear, dramatic crisis the way some cancers do. Instead, it tends to produce a slow accumulation of problems: worsening urinary accidents, skin infections that will not heal, progressive muscle loss, difficulty breathing from lung mineralization, or the onset of secondary diabetes. The owner survey data noted above suggests that the decision often comes down to quality of life for both the dog and the family rather than a specific medical threshold.
Vets who specialize in endocrinology generally advise looking for changes in the dog’s engagement with daily life. A dog that still greets you at the door, eats with enthusiasm, and enjoys short walks is a dog with quality of life, even if lab numbers are not perfect. A dog that has stopped interacting, refuses food, or seems distressed by routine activities is telling you something different. The Cushing’s-specific quality-of-life tool mentioned earlier was designed in part to help owners and vets make these assessments more systematically, rather than relying on a gut feeling during a stressful appointment.17Journal of Veterinary Internal Medicine. Development and evaluation of a health-related quality-of-life tool for dogs with Cushing’s syndrome Pulmonary mineralization with progressive oxygen deprivation is one of the clearer endpoints: two of four dogs in one case series were euthanized specifically because their breathing continued to worsen despite management.13Veterinary Radiology & Ultrasound. PULMONARY MINERALIZATION IN FOUR DOGS WITH CUSHING’S SYNDROME
There is no universally correct timeline. Some dogs do well for years with minimal intervention; others decline within months despite aggressive treatment. Staying in close communication with your vet, tracking symptoms at home, and being honest about the financial and emotional toll on your household are the most reliable guides for navigating a disease that, unlike many cancers, rarely announces its own endpoint.